Ines Verdon

Ines Verdon is a seasoned professional in clinical development with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Vice President of Clinical Development at Turnstone Biologics since August 2022, Ines has previously held the position of Vice President of Clinical Development at Rubius Therapeutics from April 2021 to April 2022. Prior roles include Executive Director and Senior Medical Director of Clinical Development at Sierra Oncology from February 2016 to March 2021, Medical Director and Global Safety Officer at Onyx Pharmaceuticals, an Amgen subsidiary, from March 2015 to December 2015, and Associate Medical Director of Pharmacovigilance at Gilead Sciences from September 2011 to March 2015.